Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of artificial intelligence ("AI") and conversational intelligence to drive revenue acceleration and operational excellence, today announced its financial results for the first quarter ended March 31, 2025. Additionally, the Company is marking the successful culmination of key milestones in its two-year strategic, financial, and operational transformation. Over this period, Marchex has transitioned into a software as a service ("SaaS") based prescriptive analytics provider powered by AI and proprietary first-party conversational data. This evolution has redefined Marchex’s technology platform and product offerings, strengthened its financial performance, and positioned the Company as an emerging leading player in the conversational intelligence and SaaS analytics space.
Q1 2025 Financial Highlights
Edwin Miller, Chief Executive Officer ("CEO"), commented, “2025 first quarter revenue was affected by some seasonal factors and the timing of when we began to benefit from certain new sales, which we believe on a run rate basis will still accrue to the benefit of our overall 2025 financial plan. As part of this, we believe 2025 second quarter revenue will be sequentially up, and adjusted EBITDA will be improved and positive (above breakeven).”
Company Announces New Share Repurchase Program
The Company today announced that its Board of Directors has authorized a new share repurchase program (the “2025 Repurchase Program”), which supersedes and replaces all prior repurchase programs. Under the 2025 Repurchase Program, the Company is authorized to repurchase up to 3,000,000 shares of the Company’s Class B common stock in the aggregate through open market and privately negotiated transactions, at such times and in such amounts as the Company deems appropriate. Repurchases may also be made under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, capital availability, and other market conditions. The 2025 Repurchase Program does not have an expiration date and may be expanded, limited or terminated at any time without prior notice.
2025 Business Update and Outlook
THE FOLLOWING FORWARD-LOOKING LOOKING STATEMENTS REFLECT MARCHEX’S EXPECTATIONS AS OF MAY 13, 2025
Marchex’s 2025 financial plan reflects its belief that during 2025, it can:
Sale of Domain Asset
Marchex recently initiated a review of its hundreds of domain assets not in use that may be potentially salable. As part of this process, one such domain, phonenumbers.com, was recently sold for proceeds to the Company of $0.8 million, which is before commissions and includes payments over time. The Company will continue to explore if there are other similar opportunities to monetize domains or other assets not in use.
Recent Strategic Product, Business and Operational Expansion
Additional New Growth Initiatives Planned for 2025
Edwin Miller, CEO, shared, “The Marchex leadership team has articulated a long-term vision to scale Marchex into a $100 million annual revenue business in the coming years. Achieving this will involve capitalizing on current momentum through launching innovative AI solutions, expanding sales channels, and deepening our presence in high-value verticals – all while continuing to differentiate on the accuracy and prescriptive power of our analytics. Our investors should see ongoing efficiency and scale across the business functions throughout 2025.”
Miller continued, “We believe that 2025 represents a key strategic inflection point. 2024 was a year of technical and operational transformation, and we are highly focused on making 2025 a year of acceleration. With a strong foundation in place and a clear vision, we are confident in our ability to deliver sustainable growth while exercising financial discipline, as well as in our ability to generate significant value for our customers and shareholders.”
Management will hold a conference call, starting at 5:00 p.m. Eastern Time on Tuesday, May 13, 2025, to discuss its first quarter 2025 financial results and other Company updates. Access to the live webcast of the conference call will be available online from the Investors section of Marchex’s website at www.marchex.com. An archived version of the webcast will also be available at the same location two hours after completion of the call.
About Marchex
Marchex harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables sales, marketing, service, operations, and executive teams to optimize customer journey experiences across omnichannel communication channels. Through our prescriptive analytics solutions, we enable the alignment of enterprise strategy, empowering businesses to increase revenue through informed decision-making and strategic execution. Marchex provides conversational intelligence AI-powered solutions for market-leading companies in leading business-to-business-to-consumer vertical markets, including several of the world’s most innovative and successful brands.
Please visit http://www.marchex.com, www.marchex.com/blog or @marchex on X, where Marchex discloses material information from time to time about the Company, its financial information, and its business.
Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenues, other financial guidance, acquisitions, dispositions, projected costs, prospects, plans and objectives of management are forward-looking statements. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. There are a number of important factors that could cause Marchex's actual results to differ materially from those indicated by such forward-looking statements including but not limited to product demand, order cancellations and delays, competition and general economic conditions. These factors are described in greater detail in the "Risk Factors" section of our most recent periodic report and registration statement filed with the Securities and Exchange Commission. All of the information provided in this release is as of May 13, 2025, and Marchex undertakes no duty to update the information provided herein.
In the event the press release contains links to third party websites or materials, the links are provided solely as a convenience to the user. Marchex is not responsible for the content of linked third-party sites or materials and does not make any representations regarding the content or accuracy thereof.
Non-GAAP Financial Information
To supplement Marchex's consolidated financial statements presented in accordance with GAAP and to provide clarity internally and externally, Marchex uses certain non-GAAP measures of financial performance and liquidity, including adjusted EBITDA and adjusted non-GAAP income (loss) per share. Financial analysts and investors may use adjusted EBITDA to help with comparative financial evaluation to make informed investment decisions. Financial analysts and investors may use adjusted non-GAAP income (loss) per share to analyze Marchex's financial performance since these groups have historically used earnings per share related measures, along with other measures, to estimate the value of a Company, to make informed investment decisions, and to evaluate a Company's operating performance compared to that of other companies in its industry.
Adjusted EBITDA represents net income (loss) before (1) interest, (2) income taxes, (3) amortization of intangible assets from acquisitions, (4) depreciation and amortization, (5) stock-based compensation expense, and (6) acquisition and disposition-related costs. Adjusted EBITDA is a metric by which Marchex has evaluated the performance of its business, to include being the basis on which Marchex's internal budgets have been based and by which Marchex's management has been evaluated. This measure is used by our management to understand and evaluate our core operating performance and trends, and management believes it provides meaningful information regarding the Company's liquidity and ability to fund its operations and financing obligations.
Adjusted non-GAAP income (loss) per share represents adjusted non-GAAP income (loss) divided by GAAP diluted shares outstanding. Adjusted non-GAAP income (loss) generally captures those items on the statement of operations that have been, or ultimately will be, settled in cash exclusive of certain items that are not indicative of Marchex’s recurring core operating results and represents net income (loss) applicable to common stockholders plus the net of tax effects of: (1) stock-based compensation expense, (2) acquisition and disposition related costs, (3) amortization of intangible assets from acquisitions, and (4) interest (income) expense and other, net.
Marchex's management believes that investors should have access to, and Marchex is obligated to provide, the same set of tools that management uses in analyzing the Company's results. These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, and should not be considered in isolation, as a substitute for, or superior to, GAAP results. Marchex’s non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar titled terms used by other companies, and accordingly, care should be exercised in understanding how Marchex defines its non-GAAP financial measures in this release. Marchex endeavors to compensate for the limitations of the non-GAAP measures presented by providing the comparable GAAP measure with equal or greater prominence, GAAP financial statements, and detailed descriptions of the reconciling items and adjustments, including quantifying such items, to derive the non-GAAP measure.
MARCHEX, INC. AND SUBSIDIARIES Consolidated Statements of Operations (In Thousands, except per share amounts) (Unaudited) |
||||||||
|
|
Three Months Ended March 31, |
||||||
|
|
2025 |
|
2024 |
||||
Revenue |
|
$ |
11,402 |
|
|
$ |
11,573 |
|
Expenses: |
|
|
|
|
||||
Cost of revenue (1) |
|
|
4,189 |
|
|
|
4,414 |
|
Sales and marketing (1) |
|
|
3,267 |
|
|
|
2,787 |
|
Product development (1) |
|
|
2,671 |
|
|
|
3,245 |
|
General and administrative (1) |
|
|
3,146 |
|
|
|
2,289 |
|
Amortization of intangible assets from acquisitions |
|
|
— |
|
|
|
151 |
|
Total operating expenses |
|
|
13,273 |
|
|
|
12,886 |
|
Loss from operations |
|
|
(1,871 |
) |
|
|
(1,313 |
) |
Interest income (expense) and other, net |
|
|
(3 |
) |
|
|
(78 |
) |
Loss before income tax expense |
|
|
(1,874 |
) |
|
|
(1,391 |
) |
Income tax expense |
|
|
108 |
|
|
|
59 |
|
Net loss applicable to common stockholders |
|
$ |
(1,982 |
) |
|
$ |
(1,450 |
) |
Basic and diluted net loss per Class A and Class B share applicable to common stockholders |
|
$ |
(0.05 |
) |
|
$ |
(0.03 |
) |
|
|
|
|
|
||||
Shares used to calculate basic net loss per share applicable to common stockholders: |
|
|
|
|
||||
Class A |
|
|
4,661 |
|
|
|
4,661 |
|
Class B |
|
|
39,060 |
|
|
|
38,393 |
|
Shares used to calculate diluted net loss per share applicable to common stockholders: |
|
|
|
|
||||
Class A |
|
|
4,661 |
|
|
|
4,661 |
|
Class B |
|
|
43,721 |
|
|
|
43,054 |
|
(1) Includes stock-based compensation allocated as follows: |
|
|
|
|
||||
Cost of revenue |
|
$ |
2 |
|
|
$ |
3 |
|
Sales and marketing |
|
|
25 |
|
|
|
88 |
|
Product development |
|
|
27 |
|
|
|
8 |
|
General and administrative |
|
|
401 |
|
|
|
334 |
|
Total |
|
$ |
455 |
|
|
$ |
433 |
|
MARCHEX, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In Thousands) |
||||||||
|
|
(Unaudited) |
|
|
||||
|
|
March 31, |
|
December 31, |
||||
|
|
2025 |
|
2024 |
||||
Assets |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
10,020 |
|
|
$ |
12,767 |
|
Accounts receivable, net |
|
|
7,584 |
|
|
|
7,072 |
|
Prepaid expenses and other current assets |
|
|
2,324 |
|
|
|
2,439 |
|
Total current assets |
|
|
19,928 |
|
|
|
22,278 |
|
Property and equipment, net |
|
|
1,720 |
|
|
|
1,811 |
|
Other assets, net |
|
|
394 |
|
|
|
397 |
|
Right-of-use lease assets |
|
|
1,033 |
|
|
|
1,156 |
|
Goodwill |
|
|
17,558 |
|
|
|
17,558 |
|
Total assets |
|
$ |
40,633 |
|
|
$ |
43,200 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
1,711 |
|
|
$ |
1,349 |
|
Accrued benefits and payroll |
|
|
585 |
|
|
|
2,133 |
|
Other accrued expenses and current liabilities |
|
|
3,919 |
|
|
|
4,197 |
|
Deferred revenue and deposits |
|
|
1,293 |
|
|
|
1,093 |
|
Operating lease liability, current |
|
|
457 |
|
|
|
495 |
|
Total current liabilities |
|
|
7,965 |
|
|
|
9,267 |
|
Deferred tax liabilities |
|
|
655 |
|
|
|
579 |
|
Operating lease liability, non-current |
|
|
639 |
|
|
|
721 |
|
Total liabilities |
|
|
9,259 |
|
|
|
10,567 |
|
Stockholders’ equity: |
|
|
|
|
||||
Class A common stock |
|
|
49 |
|
|
|
49 |
|
Class B common stock |
|
|
392 |
|
|
|
390 |
|
Additional paid-in capital |
|
|
359,093 |
|
|
|
358,372 |
|
Accumulated deficit |
|
|
(328,160 |
) |
|
|
(326,178 |
) |
Total stockholders’ equity |
|
|
31,374 |
|
|
|
32,633 |
|
Total liabilities and stockholders’ equity |
|
$ |
40,633 |
|
|
$ |
43,200 |
|
MARCHEX, INC. AND SUBSIDIARIES (In Thousands) (Unaudited) Reconciliation of Net Loss to Adjusted EBITDA |
||||||||
|
|
|
|
|
||||
|
|
Three Months Ended March 31, |
||||||
|
|
2025 |
|
2024 |
||||
Net loss applicable to common stockholders |
|
$ |
(1,982 |
) |
|
$ |
(1,450 |
) |
Interest (income) expense and other, net |
|
|
3 |
|
|
|
78 |
|
Income tax expense |
|
|
108 |
|
|
|
59 |
|
Amortization of intangible assets from acquisitions |
|
|
— |
|
|
|
151 |
|
Depreciation and amortization |
|
|
633 |
|
|
|
324 |
|
Stock-based compensation |
|
|
455 |
|
|
|
433 |
|
Adjusted EBITDA |
|
$ |
(783 |
) |
|
$ |
(405 |
) |
MARCHEX, INC. AND SUBSIDIARIES (In Thousands) (Unaudited) Reconciliation of Net Loss per Share to Adjusted Non-GAAP Loss(1) |
||||||||
|
|
Three Months Ended March 31, |
||||||
|
|
2025 |
|
2024 |
||||
Net loss applicable to common stockholders, diluted |
|
$ |
(0.05 |
) |
|
$ |
(0.03 |
) |
Stock-based compensation |
|
|
0.01 |
|
|
|
0.01 |
|
Adjusted non-GAAP loss per share |
|
$ |
(0.04 |
) |
|
$ |
(0.02 |
) |
Shares used to calculate diluted net loss per share applicable to common stockholders (GAAP) and adjusted non-GAAP loss per share |
|
|
43,721 |
|
|
|
43,054 |
|
(1) | For the purpose of computing the number of diluted shares for adjusted non-GAAP income (loss) per share, Marchex uses the accounting guidance that would be applicable for computing the number of diluted shares for GAAP net income (loss) per share. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513855435/en/
For further information, contact:
Trevor Caldwell
Marchex Investor Relations
Telephone: 206.331.3600
Email: ir@marchex.com
Or
MEDIA INQUIRIES
Marchex Corporate Communications
Telephone: 206.331.3434
Email: pr@marchex.com